Yorktown Management & Research CO Inc Amgen Inc Transaction History

Yorktown Management & Research CO Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 06, 2020	SELL	$234.65 - $260.95 $340,242 - $378,377	-1,450 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$197.81 - $242.74 $286,824 - $351,973	1,450 New	1,450 $342,000
Q2 2019 Aug 02, 2019	SELL	$166.7 - $195.41 $833,500 - $977,050	-5,000 Closed	0 $0
Q4 2018 Feb 08, 2019	SELL	$178.4 - $208.25 $303,280 - $354,025	-1,700 Reduced 25.37%	5,000 $973,000
Q2 2018 Aug 10, 2018	BUY	$166.05 - $186.51 $830,250 - $932,550	5,000 Added 294.12%	6,700 $1.24 Million
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $286,943 - $320,603	1,700	1,700 $296,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Yorktown Management & Research CO Inc, based on Form 13F filings with the SEC.

Stay updated on Yorktown Management & Research CO Inc with notifications on news.